This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
AMERISAFE Q3 Earnings Met Estimates, New Business Growth Aids
by Zacks Equity Research
AMSF's Q3 EPS meet estimates as strong policy retention and new business growth offset weaker investment income. Management announced a special cash dividend of $1.00 per share.
Amerisafe (AMSF) Q3 Earnings Meet Estimates
by Zacks Equity Research
Amerisafe (AMSF) delivered earnings and revenue surprises of 0.00% and -0.53%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Rising Sales & Declining Cash Flows: The Aflac Investor Dilemma
by Zacks Equity Research
AFL's sales surge in Japan and the United States, but declining cash flows raise questions over its growth flexibility.
Globe Life Is Trading at a Discount: Time to Load Up or Hold Off?
by Zacks Equity Research
GL builds on niche markets and agency expansion to boost premiums but rising expenses and higher debt weigh on margins.
Unum (UNM) Down 2.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Unum (UNM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GL Outperforms Industry, Trades Above 50-Day SMA: What's Next?
by Zacks Equity Research
Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.
Unum to Benefit From Growing Premium Amid Rising Expenses
by Zacks Equity Research
Unum Group sees Q2 premium gains, but rising costs, margin pressure, and weak ROE temper its performance.
Aflac Gears Up for Q2 Earnings: Ready to Quack or Set to Crack?
by Zacks Equity Research
AFL braces for Q2 results with EPS likely to decline 6.6% and revenue off 13.7% as U.S. and Japan earnings face pressure.
Allstate to Report Q2 Earnings: Can Auto Brand Strength Save the Day?
by Zacks Equity Research
ALL's Q2 earnings are likely to witness rising auto underwriting income and premium gains, facing cost headwinds.
AMERISAFE Q2 Earnings Miss Estimates on Lower Underwriting Profit
by Zacks Equity Research
AMSF's Q2 earnings miss estimates as lower underwriting profit and weaker investment income weigh on results.
Amerisafe (AMSF) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Amerisafe (AMSF) delivered earnings and revenue surprises of -3.64% and -1.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
UNM Outperforms Industry, Trades at a Premium: Should You Buy the Stock?
by Zacks Equity Research
Unum Group outperforms in 2025 as core segments expand and the stock trades at a discount to the industry average.
GL Stock Trading at a Discount to Industry at 8.22X: Time to Hold?
by Zacks Equity Research
Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.
Zacks Industry Outlook Highlights Aflac, Unum, Trupanion, Globe Life and AMERISAFE
by Zacks Equity Research
AFL, UNM, TRUP, GL and AMSF are poised to gain from rising exposure and tech adoption despite pricing pressure.
5 Accident & Health Insurance Stocks to Watch as Exposure Increases
by Tanuka De
Accident & Health Insurers AFL, UNM, TRUP, GL and AMSF are set to gain from rising underwriting exposure, despite ongoing pricing pressure.
UNM Stock Trading at a Discount to Industry at 1.23X: Time to Hold?
by Zacks Equity Research
Unum Group stock rallies on improved premium income, higher sales, strong persistency, favorable benefits experience, as well as effective capital deployment.
GL Outperforms Industry, Trades at a Discount: How to Play the Stock
by Zacks Equity Research
Globe Life gains from premium growth, higher invested assets and a strong liquidity position. Escalating expenses and high leverage are major concerns.
Aflac (AFL) Down 0.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Aflac (AFL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Amerisafe (AMSF) Down 0.1% Since Last Earnings Report?
by Zacks Equity Research
Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AMSF Stock Down 6% Despite Q1 Earnings Beat on New Business Growth
by Zacks Equity Research
AMERISAFE's Q1 results reflect premium growth and fee income surge, partly offset by weaker underwriting profits and rising underwriting expenses.
Amerisafe (AMSF) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Amerisafe (AMSF) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Amerisafe (AMSF) Q1 Earnings Top Estimates
by Zacks Equity Research
Amerisafe (AMSF) delivered earnings and revenue surprises of 1.69% and 1.41%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
UNM Stock Outperforms Industry, Trades at a Discount: Time to Hold?
by Zacks Equity Research
Unum Group stock rallies on improved premium income, higher sales, strong persistency, favorable benefits experience and effective capital deployment.
Is Annaly Capital Management (NLY) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Annaly Capital Management (NLY) and Amerisafe (AMSF) have performed compared to their sector so far this year.
Amerisafe (AMSF) Up 4.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.